The professor of neurology at VCU spoke about the possibility of pairing gene therapies for Huntington disease down the line when they are available.
“They’re really going to change how people’s disease progresses…if they work out. Even if they all work, not any single one of them is a 100% fix, especially not for 100% of people with Huntington disease.”
With recent advancements in genetics allowing for the therapeutic development pipeline to fill in the Huntington disease space, the level of excitement about treatments for the condition has risen in parallel.
Although, according to Claudia Testa, MD, PhD, a professor of neurology at Virginia Commonwealth University, it’s likely that none of these treatments will be a 1-stop cure-all for Huntington disease. Odds are, she said, that some of these treatments will be used in combination with one another. And while that prospect seems to be a topic of discussion among both manufacturers and researchers, the hope is that perhaps that expectation is incorrect.
To discuss the prospect of these gene therapies in development and how they may be used in the future, Testa sat down with NeurologyLive for an interview.